The global blood plasma market is witnessing significant growth, driven by the increasing prevalence of chronic diseases, rising awareness of plasma-derived therapies, and advancements in biopharmaceutical manufacturing. Valued at USD 31.86 billion in 2024, the market is projected to grow at a robust CAGR of 7.20% between 2025 and 2034, reaching an estimated USD 63.74 billion by 2034....
English
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic